Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this Phase 2 study is to assess the efficacy of pemetrexed-cisplatin combined with bevacizumab as induction therapy and pemetrexed-bevacizumab as maintenance therapy in the first-line treatment of patients with Stage IIIB or IV nonsquamous NSCLC, as measured by PFS.
Critère d'inclusion
- Patients who have a histologically or cytologically documented diagnosis of nonsquamous stage IIIB or stage IV NSCLC that is not amenable to curative therapy